Is a repeat EEG warranted in a 6-year-old child with a history of tonic posturing, pallor, bradycardia, and eyes rolling back, who has a normal EKG, previous EEG findings of parietal slowing, and is currently on levetiracetam for suspected seizure activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Repeat EEG in a 6-Year-Old with Parietal Slowing and Suspected Seizure Activity

A repeat EEG is warranted in this case to reassess the parietal slowing and determine if it persists, as this finding may represent evolving epileptiform activity that could guide ongoing management with levetiracetam. 1

Rationale for Repeat EEG

The presence of parietal slowing on a previous EEG, combined with clinical features of tonic posturing and eye rolling, justifies follow-up EEG monitoring to:

  • Determine if the parietal slowing has evolved into frank epileptiform discharges or seizures, as initial EEG findings in children with new-onset seizures may not capture the full epileptogenic potential 1
  • Assess whether current levetiracetam therapy is adequately suppressing epileptiform activity, particularly since the neurologist suspects "indirect seizure activity" 2
  • Clarify the diagnosis between true seizures versus non-epileptic events (such as syncope with secondary anoxic seizure-like activity), which is critical given the history of bradycardia and pallor 1

Understanding "Features Not Fully Captured"

When the neurologist mentions "features not fully captured in your description or EEG finding," this likely refers to:

  • Ictal-interictal continuum patterns that may not meet strict criteria for electrographic seizures but could still represent pathologic brain activity requiring treatment 1
  • Subtle electrographic seizures that occur without obvious clinical manifestations, which are common in children and may require continuous or prolonged EEG monitoring to detect 1
  • Peri-ictal cortical abnormalities that might explain clinical deficits and could evolve over time, necessitating repeat imaging or EEG with epilepsy-specific protocols 1

Optimal EEG Monitoring Strategy

For this clinical scenario, consider the following approach:

  • Perform video EEG monitoring for at least 24-48 hours to capture any paroxysmal events and correlate them with EEG changes, as approximately 28% of electrographic seizures are detected only after 24 hours of continuous monitoring 1
  • Use American Clinical Neurophysiology Society (ACNS) terminology to classify any EEG patterns, distinguishing between electrographic seizures (>2.5 Hz epileptiform discharges for ≥10 seconds), ictal-interictal continuum patterns, and benign variants 1
  • Ensure the EEG is performed when the child is not heavily sedated and metabolic parameters are normalized, as pharmacologic agents can interfere with accurate interpretation 1

Clinical Significance of Parietal Slowing

Parietal slowing in a 6-year-old with paroxysmal events warrants careful evaluation because:

  • Focal slowing may indicate an underlying structural lesion that was not detected on initial imaging, and MRI with an epilepsy protocol is superior to CT for identifying epileptogenic lesions 1
  • Slowing can represent post-ictal changes that resolve over time, or it may persist as a marker of ongoing epileptiform activity 1
  • In children with focal features on EEG, the yield of detecting abnormalities on MRI is significantly higher (47% in one study of status epilepticus), suggesting that persistent focal findings should prompt consideration of advanced neuroimaging 1

Levetiracetam Management Considerations

Given the current treatment with levetiracetam:

  • Levetiracetam is effective for various seizure types in children, including focal seizures with secondary generalization, with doses of 30 mg/kg showing 68-73% efficacy for acute seizures 2
  • Monitor for behavioral adverse effects, which occur in 23% of children on levetiracetam, using standardized tools like the Cornell Assessment of Pediatric Delirium (CAPD) 2
  • If repeat EEG shows persistent epileptiform activity despite levetiracetam, consider dose optimization (each 1000 mg increase raises odds of response by 40%) or addition of alternative antiepileptic therapy 2

Common Pitfalls to Avoid

Key considerations to prevent misdiagnosis:

  • Do not assume parietal slowing is benign without follow-up, as it may represent evolving epileptogenic activity that requires treatment adjustment 1
  • Distinguish between true epileptic seizures and non-epileptic events (such as paroxysmal tonic upgaze or syncope with secondary anoxic movements), which can be clarified with video EEG correlation 3
  • Avoid prophylactic continuation of antiepileptic drugs for single, self-limited seizures, but in this case with recurrent events and EEG abnormalities, ongoing treatment is appropriate 1
  • Ensure adequate benzodiazepine dosing was given initially, as inadequate first-line treatment can affect the apparent efficacy of second-line agents like levetiracetam 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Levetiracetam Efficacy and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is levETIRAcetam (levetiracetam) 750mg tablet safe for anxiety in a patient with a history of seizures?
Is lorazepam (Ativan) safe to use with lamictal (lamotrigine) in a young adult female patient with a history of seizure disorder, taking Keppra (levetiracetam), and experiencing severe emotional episodes, particularly premenstrually?
Is it safe to administer 3000mg of levetiracetam (Keppra) diluted in 100ml of Normal Saline (NS) over 30 minutes to an adult patient with a seizure disorder and normal renal function?
Is it safe to take quetiapine with levetiracetam?
What is the likely diagnosis and management for a 5-year-old patient, taking levetiracetam (levetiracetam), who experienced a possible seizure or syncopal event triggered by overheating, characterized by tonic posturing, pallor, and bradycardia, with subsequent weakness and EEG findings of rhythmic intermittent delta-theta slowing?
Are overhead pulley exercises suitable for an adult patient with shoulder pain who has recently received a corticosteroid injection?
What is the optimal management strategy for a patient presenting with chest pain suspected to be due to acute coronary syndrome (ACS), particularly regarding percutaneous coronary intervention (PCI)?
What is the management approach for a patient with elevated liver enzymes (AST and ALT)?
What is the differential diagnosis for a patient presenting with bilateral hand and wrist pain involving the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints?
What is the differential diagnosis for bilateral lower limb pain?
Can intravenous (IV) iron supplementation increase the risk of urinary tract infections (UTI) in patients, particularly those with a history of UTI or underlying urological conditions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.